Get the Stockscreener App
95.08
0.62%
0.59
After Hours:
95.08
Iradimed Corp stock is traded at $95.08, with a volume of 67,149.
It is up +0.62% in the last 24 hours and up +1.19% over the past month.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
See More
Previous Close:
$94.49
Open:
$95.56
24h Volume:
67,149
Relative Volume:
0.51
Market Cap:
$1.22B
Revenue:
$86.28M
Net Income/Loss:
$23.61M
P/E Ratio:
51.79
EPS:
1.8359
Net Cash Flow:
$23.97M
1W Performance:
-2.01%
1M Performance:
+1.19%
6M Performance:
-4.77%
1Y Performance:
+68.82%
1-Day Range:
$94.51
$97.58
1-Week Range:
$92.77
$97.58
52-Week Range:
$56.15
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Name
Iradimed Corp
Sector
Industry
Phone
(407) 677-8022
Address
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
95.08 | 1.21B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-23 | Initiated | Lake Street | Buy |
| Oct-31-17 | Resumed | ROTH Capital | Buy |
| Oct-05-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Nov-02-15 | Reiterated | ROTH Capital | Buy |
| Jul-30-15 | Reiterated | ROTH Capital | Buy |
| Jun-16-15 | Reiterated | ROTH Capital | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| Dec-23-14 | Reiterated | ROTH Capital | Buy |
View All
Iradimed Corp Stock (IRMD) Latest News
iRadimed (IRMD) Still Has a High-Quality Niche Story, but the Valuation Debate Is Getting Harder - AlphaStreet
Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline - Yahoo Finance
IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRMD|IRadimed Corp|Price:94.490|Chg%:+0.630 - TradingKey
Before market open, IRADIMED will release Q2 results July 31 - Stock Titan
IRADIMED (IRMD) As MRI Pump Upgrade Narrative Points To Fair Value Above The Stock - Sahm
IRADIMED CORPORATION (IRMD) Options Chain - Yahoo! Finance Canada
Iradimed Corp (IRMD) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Price to book forward of IRadimed Corp. – LS:A118V4 - TradingView
IRADIMED CORP (IRMD) Stock Chart - ChartMill
IRMDIradimed Corp Latest SEC Filings - Finviz
Price to book forward of IRadimed Corp. – HAN:46K - TradingView
Enterprise value to EBITDA forward of IRadimed Corp. – HAN:46K - TradingView
Enterprise value to revenue forward of IRadimed Corp. – HAN:46K - TradingView
IRadimed Corp. Actuals & Estimates (DUS:46K) - TradingView
IRadimed Corp. Actuals & Estimates (NASDAQ:IRMD) - TradingView
46K Forecast — Price Target — Prediction for 2027 - TradingView
IRadimed Corp (IRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRADIMED Corporation Form 8-K Filing Summary: Company Details and NASDAQ Listing Information (June 24, 2026) - Minichart
Iradimed (NASDAQ: IRMD) investors approve directors, auditor and pay - Stock Titan
Form 4 Iradimed Co For: 23 June By Investing.com - Investing.com Australia
IRADIMED (IRMD) CFO converts RSUs to stock and uses 2,319 shares for taxes - Stock Titan
IRadimed Corp (IRMD) Institutional Confidence - TradingKey
IRADIMED (IRMD) Stock Could Be 21.9% Undervalued on Its MRI Pump Upgrade Narrative - Sahm
IRMD Technical Analysis & Stock Price Forecast - Intellectia AI
IRadimed Corp (IRMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
IRadimed Corp (IRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRadimed Corp (IRMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Number of shareholders of IRadimed Corp. – DUS:46K - TradingView
Iradimed director sells $285,000 in company stock By Investing.com - Investing.com Australia
Insider Sell: Hilda Scharen-guivel Sells 3,000 Shares of iRadimed Corp (IRMD) - GuruFocus
Iradimed director sells $285,000 in company stock - Investing.com UK
IRADIMED (IRMD) director sells 3,000 shares in open-market trades - Stock Titan
IRMD (NASDAQ: IRMD) files notice to resell 285,000 common shares - Stock Titan
Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple - Yahoo Finance
Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares - Investing.com
IRADIMED (IRMD) CEO-linked trust sells 2,500 shares under 10b5-1 plan - Stock Titan
IRADIMED CEO Sells 7500 Common Stock Shares - asatunews.co.id
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - Yahoo Finance
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - The Motley Fool
Iradimed Corp Quarterly Report Highlights Key Growth DriversEarnings Call Q&A - The Legal Advocate
Iradimed Reports 13 Percent Revenue Growth in First Quarter of 2026 - HarianBasis.co
Iradimed Corp Reports Q1 Earnings: Three Key Areas to WatchProfit Announcement - newsline.com
IRADIMED (IRMD) CEO-linked trust sells 7,500 shares in 10b5-1 plan - Stock Titan
Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report - Insider Monkey
Iradimed Corp Stock (IRMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):